Holdings

Commodore Capital LP

As of Sep 30, 2026, Commodore Capital LP reported 31 positions worth US$1.04B. Largest: Relay Therapeutics, Inc., Enliven Therapeutics, Inc. and Alto Neuroscience, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Relay Therapeutics, Inc.12MUS$217Mno changeSep 30, 2026
Enliven Therapeutics, Inc.3.27MUS$150Mno changeSep 30, 2026
Alto Neuroscience, Inc.2.72MUS$69.5Mno changeSep 30, 2026
Spyre Therapeutics, Inc.700KUS$62.3M−147KSep 30, 2026
Amylyx Pharmaceuticals, Inc.2MUS$58.2M−3.65MSep 30, 2026
LB Pharmaceuticals Inc1.28MUS$49.2M−218KSep 30, 2026
Cogent Biosciences, Inc.1.26MUS$40.5M−1.78MSep 30, 2026
Tyra Biosciences, Inc.1.73MUS$37.7M−150KSep 30, 2026
Celldex Therapeutics, Inc.1MUS$32.4M−350KSep 30, 2026
Surrozen, Inc.885KUS$28.5MnewSep 30, 2026